I audited the repository, including the staged reports, core analysis code, CLI orchestration, tests, model adapters, and the upstream D-BETA interface. My overall assessment is:

> **The repository is a strong research-software scaffold, but the currently committed headline findings should not be treated as empirical MIMIC-IV results.**

The most important issue is not subtle statistical interpretation. It is **data provenance**: the production-facing CLI currently substitutes synthetic predictions and synthetic sensitivity inputs for actual CIIS/D-BETA scoring.

## Main audit findings

| Severity     | Finding                                                                            | Why it matters                                                                                                           |
| ------------ | ---------------------------------------------------------------------------------- | ------------------------------------------------------------------------------------------------------------------------ |
| **Critical** | Downstream CLI uses `_build_synthetic_predictions_for_cohort()`                    | `probe`, `analyze`, and `sensitivity` do not currently run the real ECG models over MIMIC waveforms.                     |
| **Critical** | Committed “empirical” numbers contradict the real cohort reports                   | The same test cohort is reported as having both 941 and 1,842 30-day deaths.                                             |
| **Critical** | Model A calibration is fit using final-test outcomes                               | The supposedly untouched test set is used in `clf_a.fit(..., y_test)`.                                                   |
| **High**     | Classical 1-df LRT ignores that B was trained using the same development outcomes  | Its extremely small p-value is not a valid conventional LRT for incremental information.                                 |
| **High**     | Sensitivity analyses use synthetic embeddings, demographics and traditional scores | Age/sex subgroup, Cornell/Sokolow, and several robustness findings are not empirical.                                    |
| **High**     | CIIS implementation has not really been clinically validated                       | 98.9% computability is not 98.9% scoring fidelity; reported score distributions also contradict each other dramatically. |
| **Medium**   | Stage 11 interpretation contains hard-coded result values                          | Interpretation can claim findings even without receiving a Stage 9 result object.                                        |
| **Medium**   | Several report numbers contradict other sections of the same report                | There are stale/manual values in the reporting layer.                                                                    |

### 1. The biggest issue: the “research pipeline” is presently a simulation path

The crucial function is:

```python
def _build_synthetic_predictions_for_cohort(...)
```

Model A is generated as:

```python
a_scores = np.clip(
  rng.gamma(shape=3.0, scale=4.0, size=n),
  0,
  45,
)
```

rather than by running CIIS on the ECGs. Model B uses 16-dimensional random embeddings:

```python
dim = 16
embs = rng.normal(size=(n, dim))
w_true = rng.normal(size=dim)

latent_risk = (
  0.08 * a_scores
  + (embs @ w_true) * 0.2
  - 1.5
)
```

and the CLI's `run_probe()` and `run_analyze()` both call this synthetic builder.

That is especially important because the README tells the reader that:

```bash
uv run ecg-alignment pipeline
```

runs the complete research pipeline and labels the resulting quantities as **Key Empirical Findings**.

So at present:

[
\boxed{
\text{repository has real model adapters}
\neq
\text{CLI actually uses those adapters}
}
]

The real `DbetaAdapter` is present and its interface is credible: it passes `[batch, 12, 5000]` waveforms into the pretrained model and retrieves a 768-dimensional `pooler_output`.  That matches the official D-BETA usage exactly.

In other words, this is very fixable. The building blocks exist; they simply have not yet been connected into the downstream pipeline.

### 2. The reported empirical numbers do not have a consistent provenance

The frozen cohort report says:

[
N_{\text{test}}=32,256,\qquad
D_{30}=941,\qquad
\text{mortality}=2.92%.
]

The independently documented outcome construction agrees: overall 30-day mortality is 4,701/161,279 = 2.91%.

But `reports/primary-results.md` claims, for exactly the same test-set size:

[
N_{\text{test}}=32,256,\qquad
D_{30}=1,842,\qquad
\text{mortality}=5.71%.
]

Those cannot both be true.

There are similar contradictions **inside the primary report itself**. Its executive summary gives H4 as:

[
\Delta G^2=384.62,\qquad
\Delta AUROC=0.0542,
]

but the detailed section gives:

[
\Delta G^2=649.40,\qquad
\Delta AUROC=0.0886.
]

The detailed AUROC difference is arithmetically compatible with its table:

[
0.7831-0.6945=0.0886.
]

The PR description also uses 649.40 and 0.0886.

Meanwhile, the README mixes the two versions: LRT 384.62 with (\Delta AUROC=0.0886).

That strongly suggests the Markdown findings were assembled from illustrative/static values rather than regenerated from one authoritative result artifact.

### 3. There is actual final-test leakage in Model A calibration

This should be fixed even after the synthetic path is removed.

Inside `run_primary_analysis()`:

```python
clf_a.fit(
  a_scores.reshape(-1, 1),
  y_test,
)
probs_a_cal = clf_a.predict_proba(...)
```

So the final-test mortality labels are used to calibrate Model A before its Brier-score comparison.

That violates the repository's own claim that the final test set is untouched.

The correct sequence is:

[
\text{development data}
\rightarrow
\text{fit A calibration}
]

then freeze it and apply:

[
\text{test A scores}
\rightarrow
\text{frozen calibrator}
\rightarrow
P_A.
]

Or, because CIIS was never designed as a 30-day mortality probability, an even cleaner primary comparison would be to restrict A/B head-to-head evaluation to rank-based discrimination and separately fit prespecified calibration mappings on development data.

### 4. The LRT should not be the inferential centerpiece

The incremental-information implementation fits:

[
Y\sim f(A)
]

and

[
Y\sim f(A)+B
]

on the development set and computes the usual likelihood-ratio statistic with one additional degree of freedom.

The problem is that (B) is itself produced by a **768-dimensional supervised probe previously trained using those development outcomes**.

So (B) is not an externally fixed one-dimensional predictor when the LRT is performed. Treating its introduction as simply one newly estimated parameter ignores the upstream estimation of the probe.

Consequently,

[
\chi^2_1
]

is not an appropriate reference distribution for that naïve LRT.

For this experiment I would make the much cleaner held-out quantities primary:

[
\Delta AUROC,\qquad
\Delta AUPRC,\qquad
\Delta\text{log-loss},\qquad
\Delta\text{Brier}.
]

All can be estimated on the untouched test cohort with paired patient-level bootstrap intervals.

If formal conditional inference is wanted, cross-fit the entire B probe so that the (B_i) entering an inferential model were generated without training on (Y_i).

### 5. The CIIS implementation needs a different kind of validation

There is a good amount of serious engineering in `traditional.py`: discrete scoring functions, waveform filtering, QRS detection, median-beat extraction, and per-lead feature extraction.

And CIIS itself is certainly legitimate: the original *Circulation* paper describes a multivariate ECG score ultimately represented as a 12-item visual coding procedure. ([PubMed][1]) Subsequent epidemiologic implementations describe it as 11 discrete plus four continuous ECG features. ([PubMed Central (PMC)][2])

But the repository reports:

> 98.90% technical fidelity

based essentially on whether its custom waveform delineator successfully emits a score.

I'd call this **technical completion rate**, not fidelity.

More concerning is the distribution. Stage 2 reports:

* median CIIS = 27.65;
* normal = 7.18%;
* probable infarction = **70.98%**.

The Stage 9 report instead says:

* normal = **53.4%**;
* probable infarction = 12.3%.

A different cohort could shift the distribution, but a swing of this magnitude needs explanation and, given the synthetic Stage 9 A scores, is now explained by the provenance problem.

Before the real experiment, I'd validate the custom CIIS extractor on a few hundred ECGs against either a trusted implementation or independently adjudicated component measurements. The hard part of CIIS here is **waveform measurement fidelity**, not adding the item scores.

### 6. None of the current sensitivity “findings” should be interpreted yet

This is particularly clear in `run_sensitivity()`.

It generates:

```python
dev_emb = rng.normal(...)
test_emb = rng.normal(...)
```

and fake demographics:

```python
"<65" if i % 2 == 0 else ">=65"
"F" if i % 3 == 0 else "M"
```

and random alternative ECG scores:

```python
"Cornell Voltage": rng.uniform(...)
"Sokolow-Lyon Voltage": rng.uniform(...)
```

Yet the sensitivity report presents detailed differences by real-looking age, sex, Cornell, Sokolow-Lyon, admission-anchored cohort, and CarDSLab performance.

Those tables should therefore be treated as **report-format examples**, not research findings.

The tests reinforce this interpretation: the CLI integration tests deliberately create tiny synthetic MIMIC CSVs without real WFDB ECG waveforms and successfully exercise `probe`, `analyze`, and the full pipeline.  If those commands were truly scoring CIIS and D-BETA, they could not complete without ECG waveform files.

## What I think of the reported scientific pattern

If the eventual real run reproduces something like:

[
\rho(A,B)\approx0.5,
]

[
AUROC_B>AUROC_A,
]

and, especially,

[
P(Y\mid A\text{ stratum},B_{high})

>

P(Y\mid A\text{ stratum},B_{low}),
]

then I would consider that genuinely interesting.

The **within-CIIS-stratum gradient** remains the most informative part of the design. It asks whether the learned ECG representation contains outcome information not compressed into traditional ECG morphology scoring.

The discordance analysis would also be very intuitive. For example,

[
P(Y\mid A_{\text{low}},B_{\text{high}})
]

versus

[
P(Y\mid A_{\text{low}},B_{\text{low}})
]

directly expresses what the transformer might be adding.

But I would change some of the language even for valid empirical results. A Spearman (\rho=0.512) does **not** justify saying there is “shared variance ~26%”; squaring a rank correlation does not have that simple variance-decomposition interpretation. Likewise, conditional prediction beyond CIIS does not establish that the representation is “orthogonal.” And “undeniable orthogonal prognostic value,” currently used in the README, is far too strong.

“Partially aligned but complementary prognostic information” would be much better.

The pretraining-contamination framing, by contrast, is handled correctly. D-BETA is indeed a peer-reviewed multimodal ECG-text model from ICML 2025. ([Proceedings of Machine Learning Research][3]) The repository consistently recognizes that MIMIC evaluation should be called **in-domain probing**, not external validation.

## Some smaller implementation issues

`compute_global_alignment()` fills an empty 2-D risk-surface cell with the **overall event rate** rather than missing/NaN.  That can create apparent structure where no observations exist. I'd return `NaN` and keep an accompanying cell-count matrix.

The A-high discordance risk-difference CI is also currently constructed as:

```python
ci_lower=diff_ahigh_point,
ci_upper=diff_ahigh_point,
```

so it is not bootstrapped at all.  Yet the static report gives it a non-degenerate 95% CI, another indication that report values are disconnected from the generator.

Stage 11 has the same provenance problem. `synthesize_research_interpretation()` accepts real results optionally, but when none are supplied it instantiates hard-coded values such as (\rho=0.512), the CIIS category counts, and RR=2.35. The CLI calls it without a Stage 9 result.

## What is genuinely good already

I would preserve most of the architecture. The separation into `cohort`, `outcomes`, `split`, `probe`, `analysis`, and model adapters is sensible. The D-BETA adapter matches the model's documented API. The patient-disjoint split logic is explicit. The predictor-information firewall is a good design convention. Tests are extensive. `uv`, typing, frozen dataclasses, and the generally functional decomposition fit the project well. The dependency/tool setup is tidy too.

So I would **repair rather than redesign** the repository.

## Recommended rescue sequence

1. Move `_build_synthetic_predictions_for_cohort()` into an explicitly named `demo`/`simulation` module and make it impossible for `pipeline` or `analyze` to invoke accidentally.
2. Wire the real path:
   `index cohort → WFDB waveform → CIIS + D-BETA embedding → frozen probe → persisted prediction artifact → analysis`.
3. Persist one authoritative row-level protected artifact outside Git containing IDs, split, outcome, A, A category, B/logit and validity flags; every report should derive from that artifact.
4. Add a run manifest containing Git SHA, D-BETA revision, `uv.lock` hash, cohort counts, event counts, model-valid counts, seed, and prediction-artifact checksum.
5. Make reports **fully generated**, with no manually duplicated numerical executive summaries.
6. Refit any A calibration using development data only; keep final-test labels completely inaccessible until evaluation.
7. Replace the naïve LRT with held-out paired performance differences as the primary incremental-information analysis, or implement proper cross-fitting.
8. Validate CIIS measurement accuracy before performing the full cohort run.
9. Regenerate Stage 9–11 and the README only after the real pipeline completes; until then label current values “illustrative/simulated.”

After that real run, this could become a quite compelling exploratory study. Right now I would describe the repository as **“implementation-complete analysis framework; empirical model-alignment run pending”**, not as a completed study with confirmed H1–H4. The architecture has done useful work; the next task is to make the **data lineage as rigorous as the software structure**.

[1]: https://pubmed.ncbi.nlm.nih.gov/7249294/?utm_source=chatgpt.com "Cardiac infarction injury score: an electrocardiographic coding scheme for ischemic heart disease."
[2]: https://pmc.ncbi.nlm.nih.gov/articles/PMC4336466/?utm_source=chatgpt.com "Subclinical Myocardial Injury Identified by Cardiac Infarction/Injury Score and the Risk of Mortality in Men and Women Free of Cardiovascular Disease - PMC"
[3]: https://proceedings.mlr.press/v267/pham-hung25a.html?utm_source=chatgpt.com "Boosting Masked ECG-Text Auto-Encoders as Discriminative Learners"
